Biopharmaceutical company Ziopharm Oncology (ZIOP -5.5%) says it plans to sell an undisclosed...

|By:, SA News Editor

Biopharmaceutical company Ziopharm Oncology (ZIOP -5.5%) says it plans to sell an undisclosed number of shares of common stock to fund the development of its drug candidates, as well as for general corporate and working capital purposes.